Acute coronary syndromes BA Bergmark, N Mathenge, PA Merlini, MB Lawrence-Wright, ... The Lancet 399 (10332), 1347-1358, 2022 | 233 | 2022 |
Fat embolism syndrome E Kosova, B Bergmark, G Piazza Circulation 131 (3), 317-320, 2015 | 159 | 2015 |
Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis MS Sabatine, BA Bergmark, SA Murphy, P T O'Gara, PK Smith, ... The Lancet 398 (10318), 2247-2257, 2021 | 155 | 2021 |
Understanding suicide and disability through three major disabling conditions: Intellectual disability, spinal cord injury, and multiple sclerosis MJ Giannini, B Bergmark, S Kreshover, E Elias, C Plummer, E O'Keefe Disability and health journal 3 (2), 74-78, 2010 | 119 | 2010 |
Effect of vupanorsen on non–high-density lipoprotein cholesterol levels in statin-treated patients with elevated cholesterol: TRANSLATE-TIMI 70 BA Bergmark, NA Marston, CR Bramson, M Curto, V Ramos, A Jevne, ... Circulation 145 (18), 1377-1386, 2022 | 110 | 2022 |
Initial findings from the North American COVID-19 myocardial infarction registry S Garcia, P Dehghani, C Grines, L Davidson, KR Nayak, J Saw, ... Journal of the American College of Cardiology 77 (16), 1994-2003, 2021 | 105 | 2021 |
Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy PE Bravo, BA Bergmark, T Vita, VR Taqueti, A Gupta, S Seidelmann, ... European heart journal 39 (4), 316-323, 2018 | 96 | 2018 |
An exploratory analysis of proprotein convertase subtilisin/kexin type 9 inhibition and aortic stenosis in the FOURIER trial BA Bergmark, ML O’Donoghue, SA Murphy, JF Kuder, MV Ezhov, ... JAMA cardiology 5 (6), 709-713, 2020 | 94 | 2020 |
Metformin use and clinical outcomes among patients with diabetes mellitus with or without heart failure or kidney dysfunction: observations from the SAVOR-TIMI 53 trial BA Bergmark, DL Bhatt, DK McGuire, A Cahn, O Mosenzon, PG Steg, ... Circulation 140 (12), 1004-1014, 2019 | 73 | 2019 |
US medical specialty global health training and the global burden of disease VB Kerry, RP Walensky, AC Tsai, RW Bergmark, BA Bergmark, C Rouse, ... Journal of Global Health 3 (2), 2013 | 71 | 2013 |
Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk BA Bergmark, BM Scirica, PG Steg, CL Fanola, Y Gurmu, O Mosenzon, ... European Heart Journal 39 (24), 2255-2262, 2018 | 59 | 2018 |
Klotho, fibroblast growth factor‐23, and the renin–angiotensin system—an analysis from the PEACE trial BA Bergmark, JA Udell, DA Morrow, P Jarolim, JF Kuder, SD Solomon, ... European journal of heart failure 21 (4), 462-470, 2019 | 46 | 2019 |
Early aspirin use and the development of cardiac allograft vasculopathy M Kim, BA Bergmark, TA Zelniker, MR Mehra, GC Stewart, DS Page, ... The Journal of Heart and Lung Transplantation 36 (12), 1344-1349, 2017 | 43 | 2017 |
Association of fibroblast growth factor 23 with recurrent cardiovascular events in patients after an acute coronary syndrome: a secondary analysis of a randomized clinical trial BA Bergmark, JA Udell, DA Morrow, CP Cannon, DL Steen, P Jarolim, ... JAMA cardiology 3 (6), 473-480, 2018 | 41 | 2018 |
Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trial BA Bergmark, CP Cannon, WB White, P Jarolim, Y Liu, MP Bonaca, ... Diabetes, Obesity and Metabolism 19 (7), 962-969, 2017 | 39 | 2017 |
Effect of evolocumab on complex coronary disease requiring revascularization K Oyama, RHM Furtado, A Fagundes Jr, TA Zelniker, M Tang, J Kuder, ... Journal of the American College of Cardiology 77 (3), 259-267, 2021 | 35 | 2021 |
The Surgeon General’s call to action to improve the health and wellness of persons with disabilities: Historical review, rationale, and implications 5 years after publication RH Carmona, M Giannini, B Bergmark, J Cabe Disability and health journal 3 (4), 229-232, 2010 | 34 | 2010 |
Society for cardiac angiography and interventions, the Canadian Association of Interventional Cardiology, and the American College of Cardiology Interventional Council. Initial … S Garcia, P Dehghani, C Grines, L Davidson, KR Nayak, J Saw, ... J Am Coll Cardiol 77 (16), 1994-2003, 2021 | 32 | 2021 |
Effect of evolocumab on acute arterial events across all vascular territories: results from the FOURIER trial K Oyama, RP Giugliano, M Tang, MP Bonaca, JL Saver, SA Murphy, ... European Heart Journal 42 (47), 4821-4829, 2021 | 31 | 2021 |
Risk assessment in patients with diabetes with the TIMI risk score for atherothrombotic disease BA Bergmark, DL Bhatt, E Braunwald, DA Morrow, PG Steg, Y Gurmu, ... Diabetes Care 41 (3), 577-585, 2018 | 31 | 2018 |